港股异动 | 国药控股(01099)涨超3% 本周将发三季度业绩 国药股份第三季纯利同比增长13.1%

Core Viewpoint - China National Pharmaceutical Group (国药控股) shares rose over 3%, currently trading at HKD 19.33 with a transaction volume of HKD 71.91 million [1] Company Performance - China National Pharmaceutical Group will hold a board meeting on October 24 to consider and approve the unaudited quarterly results for the nine months ending September 30, 2025 [1] - Its subsidiary, China National Pharmaceutical Co., reported a third-quarter revenue of RMB 13.747 billion, representing a year-on-year increase of 3.58% [1] - The net profit attributable to shareholders for the same period was RMB 544 million, showing a year-on-year growth of 13.10% [1]